Crossmark

Dapagliflozin-intermittent fasting combination maximizes weight and metabolic regulation through AMPK/sirtuins/clock genes and gut microbiota signaling in high-fat diet-induced obesity: a novel anti-obesity approach

Crossref DOI link: https://doi.org/10.1186/s13578-026-01557-4

Published Online: 2026-04-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Senousy, Mahmoud A.

Abo-Elmaaty, Rana Mohamed

Nabil Omar, Nesreen

Abdelgawad, Hanan M.
Funding

Funding for this research was provided by:

Cairo University
License Information

Text and Data Mining valid from 2026-04-12

Version of Record valid from 2026-04-17
More Information

Article History

Received: 22 November 2025

Accepted: 2 March 2026

First Online: 12 April 2026

Declarations

:

: The Institutional Review Board of the Faculty of Pharmacy, Cairo University, Egypt gave its clearance to the study (approval code: BC3058). The research ethics committee at the Faculty of Medicine, Ain Shams University (FMASU-REC) also approved the work.

: Not applicable.

: There are no conflicts to declare.

Document is current

Any future updates will be listed below